Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Kura Oncology Analyst Ratings and Price Targets | NASDAQ:KURA | Benzinga
Kura Oncology Inc has a consensus price target of $25.17 based on the ratings of 14 analysts. The high is $40 issued by HC Wainwright & Co. on April 28, 2025. The low is $10 issued by Scotiabank on January 8, 2025. The 3 most-recent analyst ratings were released by Mizuho, Barclays, and JMP Securities on May 19, 2025, May 2, 2025, and April 29, 2025, respectively. With an average price target of $23 between Mizuho, Barclays, and JMP Securities, there's an implied 287.21% upside for Kura Oncology Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Mizuho
Barclays
JMP Securities
HC Wainwright & Co.
UBS
1calculated from analyst ratings
Analyst Ratings for Kura Oncology
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/19/2025 | Buy Now | 405.05% | Mizuho | Mara Goldstein56% | $32 → $30 | Maintains | Outperform | Get Alert |
| 05/02/2025 | Buy Now | 85.19% | Barclays | Peter Lawson42% | $32 → $11 | Maintains | Overweight | Get Alert |
| 04/29/2025 | Buy Now | 371.38% | JMP Securities | Reni Benjamin47% | $28 → $28 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/28/2025 | Buy Now | 573.4% | HC Wainwright & Co. | Joseph Pantginis46% | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
| 03/06/2025 | Buy Now | 135.69% | UBS | David Dai26% | $27 → $14 | Maintains | Buy | Get Alert |
| 02/27/2025 | Buy Now | 573.4% | HC Wainwright & Co. | Joseph Pantginis46% | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
| 02/06/2025 | Buy Now | 371.38% | JMP Securities | Reni Benjamin47% | $28 → $28 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/06/2025 | Buy Now | 506.06% | Wedbush | Robert Driscoll44% | $34 → $36 | Maintains | Outperform | Get Alert |
| 02/06/2025 | Buy Now | 573.4% | HC Wainwright & Co. | Joseph Pantginis46% | $37 → $40 | Maintains | Buy | Get Alert |
| 01/08/2025 | Buy Now | 68.35% | Scotiabank | George Farmer39% | $18 → $10 | Maintains | Sector Perform | Get Alert |
| 12/09/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek40% | — | Reiterates | Overweight → Overweight | Get Alert |
| 11/26/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek40% | — | Reiterates | → Overweight | Get Alert |
| 11/22/2024 | Buy Now | 388.22% | B of A Securities | Jason Zemansky72% | $36 → $29 | Maintains | Buy | Get Alert |
| 11/21/2024 | Buy Now | — | TD Cowen | Phil Nadeau66% | — | Reiterates | → Buy | Get Alert |
| 11/21/2024 | Buy Now | 371.38% | Jefferies | Roger Song35% | $32 → $28 | Maintains | Buy | Get Alert |
| 11/21/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek40% | — | Reiterates | → Overweight | Get Alert |
| 11/21/2024 | Buy Now | 522.9% | HC Wainwright & Co. | Joseph Pantginis46% | $32 → $37 | Maintains | Buy | Get Alert |
| 11/19/2024 | Buy Now | 438.72% | JMP Securities | Reni Benjamin47% | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/18/2024 | Buy Now | 438.72% | HC Wainwright & Co. | Joseph Pantginis46% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | 438.72% | HC Wainwright & Co. | Joseph Pantginis46% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 11/06/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek40% | — | Reiterates | → Overweight | Get Alert |
| 11/06/2024 | Buy Now | 438.72% | HC Wainwright & Co. | Joseph Pantginis46% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 10/24/2024 | Buy Now | 354.55% | UBS | David Dai26% | → $27 | Initiates | → Buy | Get Alert |
| 10/24/2024 | Buy Now | 438.72% | HC Wainwright & Co. | Joseph Pantginis46% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 10/14/2024 | Buy Now | 219.87% | Stifel | Bradley Canino40% | $26 → $19 | Downgrade | Buy → Hold | Get Alert |
| 09/09/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek40% | — | Reiterates | → Overweight | Get Alert |
| 08/12/2024 | Buy Now | 438.72% | JMP Securities | Reni Benjamin47% | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/12/2024 | Buy Now | 438.72% | HC Wainwright & Co. | Joseph Pantginis46% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek40% | — | Reiterates | → Overweight | Get Alert |
| 08/09/2024 | Buy Now | 522.9% | Wedbush | Robert Driscoll44% | $37 → $37 | Reiterates | Outperform → Outperform | Get Alert |
| 08/09/2024 | Buy Now | 337.71% | Stifel | Bradley Canino40% | $28 → $26 | Maintains | Buy | Get Alert |
| 06/24/2024 | Buy Now | 438.72% | HC Wainwright & Co. | Joseph Pantginis46% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 06/18/2024 | Buy Now | 438.72% | JMP Securities | Reni Benjamin47% | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/16/2024 | Buy Now | 438.72% | JMP Securities | Reni Benjamin47% | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/14/2024 | Buy Now | 438.72% | HC Wainwright & Co. | Joseph Pantginis46% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 05/06/2024 | Buy Now | 438.72% | JMP Securities | Reni Benjamin47% | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/03/2024 | Buy Now | 522.9% | Wedbush | Robert Driscoll44% | $37 → $37 | Reiterates | Outperform → Outperform | Get Alert |
| 05/03/2024 | Buy Now | 438.72% | HC Wainwright & Co. | Joseph Pantginis46% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 04/22/2024 | Buy Now | 438.72% | HC Wainwright & Co. | Joseph Pantginis46% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 03/06/2024 | Buy Now | 438.72% | HC Wainwright & Co. | Joseph Pantginis46% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2024 | Buy Now | 371.38% | Stifel | Bradley Canino40% | $27 → $28 | Maintains | Buy | Get Alert |
| 02/28/2024 | Buy Now | 438.72% | HC Wainwright & Co. | Joseph Pantginis46% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2024 | Buy Now | 522.9% | Wedbush | Robert Driscoll44% | $37 → $37 | Reiterates | Outperform → Outperform | Get Alert |
| 01/31/2024 | Buy Now | 438.72% | Mizuho | Mara Goldstein56% | $26 → $32 | Maintains | Buy | Get Alert |
| 01/31/2024 | Buy Now | 438.72% | JMP Securities | Reni Benjamin47% | $22 → $32 | Maintains | Market Outperform | Get Alert |
| 12/22/2023 | Buy Now | 337.71% | Mizuho | Mara Goldstein56% | → $26 | Initiates | → Buy | Get Alert |
| 12/08/2023 | Buy Now | 438.72% | HC Wainwright & Co. | Joseph Pantginis46% | → $32 | Reiterates | Buy → Buy | Get Alert |
| 11/03/2023 | Buy Now | 522.9% | Wedbush | Robert Driscoll44% | $40 → $37 | Maintains | Outperform | Get Alert |
| 10/18/2023 | Buy Now | 573.4% | Wedbush | Robert Driscoll44% | → $40 | Reiterates | Outperform → Outperform | Get Alert |
| 09/07/2023 | Buy Now | 405.05% | Cantor Fitzgerald | Li Watsek40% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 08/11/2023 | Buy Now | 421.89% | B of A Securities | Jason Zemansky72% | → $31 | Initiates | → Buy | Get Alert |
| 08/04/2023 | Buy Now | 304.04% | Stifel | Bradley Canino40% | $25 → $24 | Maintains | Buy | Get Alert |
| 07/27/2023 | Buy Now | 76.77% | Scotiabank | George Farmer39% | → $10.5 | Initiates | → Sector Perform | Get Alert |
| 07/21/2023 | Buy Now | 405.05% | Cantor Fitzgerald | Li Watsek40% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 06/13/2023 | Buy Now | 405.05% | Cantor Fitzgerald | Li Watsek40% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 06/13/2023 | Buy Now | 270.37% | JMP Securities | Reni Benjamin47% | → $22 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/12/2023 | Buy Now | 438.72% | HC Wainwright & Co. | Joseph Pantginis46% | → $32 | Reiterates | Buy → Buy | Get Alert |
| 06/12/2023 | Buy Now | 320.88% | Stifel | Bradley Canino40% | $24 → $25 | Maintains | Buy | Get Alert |
| 05/17/2023 | Buy Now | 421.89% | BTIG | Justin Zelin40% | → $31 | Initiates | → Buy | Get Alert |
| 05/11/2023 | Buy Now | 337.71% | Credit Suisse | Tiago Fauth44% | → $26 | Reiterates | Outperform → Outperform | Get Alert |
| 05/11/2023 | Buy Now | 438.72% | HC Wainwright & Co. | Joseph Pantginis46% | → $32 | Reiterates | Buy → Buy | Get Alert |
| 04/17/2023 | Buy Now | 270.37% | JMP Securities | Reni Benjamin47% | → $22 | Reiterates | → Market Outperform | Get Alert |
| 02/24/2023 | Buy Now | 438.72% | HC Wainwright & Co. | Joseph Pantginis46% | → $32 | Reiterates | → Buy | Get Alert |
| 02/10/2023 | Buy Now | 438.72% | HC Wainwright & Co. | Joseph Pantginis46% | → $32 | Reiterates | → Buy | Get Alert |
| 01/31/2023 | Buy Now | 320.88% | Stifel | Bradley Canino40% | → $25 | Initiates | → Buy | Get Alert |
| 07/13/2022 | Buy Now | 388.22% | Credit Suisse | Tiago Fauth44% | $27 → $29 | Maintains | Outperform | Get Alert |
| 07/12/2022 | Buy Now | 405.05% | Cantor Fitzgerald | Li Watsek40% | → $30 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Kura Oncology (KURA) stock?
The latest price target for Kura Oncology (NASDAQ:KURA) was reported by Mizuho on May 19, 2025. The analyst firm set a price target for $30.00 expecting KURA to rise to within 12 months (a possible 405.05% upside). 33 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kura Oncology (KURA)?
The latest analyst rating for Kura Oncology (NASDAQ:KURA) was provided by Mizuho, and Kura Oncology maintained their outperform rating.
When was the last upgrade for Kura Oncology (KURA)?
There is no last upgrade for Kura Oncology
When was the last downgrade for Kura Oncology (KURA)?
The last downgrade for Kura Oncology Inc happened on October 14, 2024 when Stifel changed their price target from $26 to $19 for Kura Oncology Inc.
When is the next analyst rating going to be posted or updated for Kura Oncology (KURA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kura Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kura Oncology was filed on May 19, 2025 so you should expect the next rating to be made available sometime around May 19, 2026.
Is the Analyst Rating Kura Oncology (KURA) correct?
While ratings are subjective and will change, the latest Kura Oncology (KURA) rating was a maintained with a price target of $32.00 to $30.00. The current price Kura Oncology (KURA) is trading at is $5.94, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
